| Title: | Risk factors, structural brain abnormalities and cognitive function in individuals with type 2 diabetes |
| Lead Institution: | Maastricht University Medical Center |
| Principal investigator: | Dr Thomas van Sloten |
Application 60842
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
Individuals with diabetes have a higher risk of developing dementia compared to individuals without diabetes. The extent to which this excess risk may be reduced by current treatment is unclear. Current treatment consists of targeting multiple factors, including high blood sugar levels, elevated blood pressure, being overweight, smoking and elevated protein levels in urine. In this project, we will evaluate whether the higher risk of dementia in diabetes could be reduced by this multifactorial treatment. This will inform patients and medical doctors about the potential beneficial effects of current treatments. The estimated project duration is 12 months.1 Publication
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 12674 | Association of Type 2 Diabetes, According to the Number of Risk Factors Within Target Range, With Structural Brain Abnormalities, Cognitive Performance, and Risk of Dementia | April C.E. van Gennip (+15) | 2021 | Diabetes Care |
Enabling scientific discoveries that improve human health